Skip to main content
. 2024 Jul 22;184(9):1083–1093. doi: 10.1001/jamainternmed.2024.3270

Table 1. Pregnancy Characteristics Overall and by Prenatal Cannabis Use.

Pregnancy characteristics No. (%) Standardized differencea
Overall (N = 316 722) Prenatal cannabis use
Yes (n = 20 053 [6.3%]) No (n = 296 669 [93.7%])
Age at pregnancy onset, y
<18 2994 (0.9) 617 (3.1) 2377 (0.8) 0.68
18-24 46 021 (14.5) 7541 (37.6) 38 480 (13.0)
25-30 87 882 (27.7) 5469 (27.3) 82 413 (27.8)
31-35 113 020 (35.7) 4250 (21.2) 108 770 (36.7)
≥36 66 805 (21.1) 2176 (10.9) 64 629 (21.8)
Self-reported race and ethnicity
Hispanic 83 145 (26.3) 5583 (27.8) 77 562 (26.1) 0.80
Non-Hispanic
American Indian/Alaska Nativeb 1078 (0.3) 144 (0.1) 934 (0.3)
Asian/Pacific Islander 84 039 (26.5) 1191 (5.9) 82 848 (27.9)
Black 20 053 (6.3) 4480 (22.3) 15 573 (5.2)
White 118 333 (37.4) 7750 (38.6) 110 583 (37.3)
Multiracialb 4540 (1.3) 622 (0.2) 3918 (1.2)
Unknownb 5534 (1.8) 283 (0.1) 5251 (1.7)
Parity
0 129 585 (40.9) 9906 (49.4) 119 679 (40.3) 0.25
1 110 434 (34.9) 5471 (27.3) 104 963 (35.4)
≥2 65 908 (20.8) 3408 (17.0) 62 500 (21.1)
Unknown 10 795 (3.4) 1268 (6.3) 9527 (3.2)
Prenatal care initiation
Adequate plus (months 1-2) 198 083 (62.5) 11 932 (59.5) 186 151 (62.7) 0.13
Adequate (months 3-5) 99 481 (31.4) 6619 (33.0) 92 862 (31.3)
Intermediate (months 5-6) 11 297 (3.6) 962 (4.8) 10 335 (3.5)
Inadequate (months 7+) 7861 (2.5) 540 (2.7) 7321 (2.5)
Insured by Medicaid 28 803 (9.1) 5049 (25.2) 23 754 (8.0) 0.47
Neighborhood deprivation index, quartile
1 (Least deprivation) 74 902 (23.6) 2641 (13.2) 72 261 (24.4) 0.41
2 74 934 (23.7) 3987 (19.9) 70 947 (23.9)
3 74 907 (23.7) 5315 (26.5) 69 592 (23.5)
4 (Most deprivation) 74 916 (23.7) 7510 (37.5) 67 406 (22.7)
Unknown 17 063 (5.4) 600 (3.0) 16 463 (5.5)
Noncannabis substance use during pregnancy
Alcohol 29 565 (9.3) 3987 (19.9) 25 578 (8.6) 0.33
Nicotine 14 281 (4.5) 4499 (22.4) 9782 (3.3) 0.60
Opioids 22 054 (7.0) 2561 (12.8) 19 493 (6.6) 0.21
Stimulants 1712 (0.5) 598 (3.0) 1114 (0.4) 0.20
Anxiety or sleep medications 9163 (2.9) 1370 (6.8) 7793 (2.6) 0.20
Prepregnancy BMI categories
Underweight (<18.5) 7164 (2.3) 537 (2.7) 6627 (2.2) 0.24
Normal (18.5-24.9) 137 375 (43.4) 6945 (34.6) 130 430 (44.0)
Overweight (25-29.9) 83 426 (26.3) 5275 (26.3) 78 151 (26.3)
Obesity (≥30) 73 367 (23.2) 6433 (32.1) 66 934 (22.6)
Unknown 15 390 (4.9) 863 (4.3) 14 527 (4.9)
Diagnoses and medications
2 y Before pregnancy
Diabetes 4026 (1.3) 222 (1.1) 3804 (1.3) −0.02
1 y Before pregnancy through first prenatal visit
Mood/anxiety disorder 34 984 (11.0) 4514 (22.5) 30 470 (10.3) 0.34
Other psychiatric disorder 7498 (2.4) 1269 (6.3) 6229 (2.1) 0.21
Substance use disorder diagnosis (other than cannabis) 11 220 (3.5) 3251 (16.2) 7969 (2.7) 0.48
Pregnancy onset through first prenatal visit
Nausea and vomiting 35 639 (11.3) 4642 (23.1) 30 997 (10.4) 0.34
Antidepressant medication use 6441 (2.0) 865 (4.3) 5576 (1.9) 0.14
Frequency of cannabis use
Daily 1930 (0.6) 1930 (9.6) 0 1.31
Weekly 2345 (0.7) 2345 (11.7) 0
Monthly or less 4892 (1.5) 4892 (24.4) 0
Never 296 669 (93.7) 0 296 669 (100)
Unknown frequency, positive toxicology results 10 886 (3.4) 10 886 (54.3) 0
Fetal outcome
Live birth 314 480 (99.3) 19 880 (99.1) 294 600 (99.3) 0.20
Stillbirth 1510 (0.5) 114 (0.6) 1396 (0.5)
Therapeutic abortion 732 (0.2) 59 (0.3) 673 (0.2)

Abbreviation: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared).

a

Standardized difference is the difference in proportions divided by the standard error; imbalance defined as absolute value greater than 0.20 (small effect size).

b

These categories were collapsed in the models.